We have all heard the statistics:19% of clinical trials terminate due to failed recruitment or complete with less than 85% of expected enrollment leading to up to $8M in lost revenue to sponsors per day a trial is delayed. This panel will feature clinical research innovators focused on implementing novel approaches to long standing industry challenges. Each panel member represents a key industry stakeholder from companies that foster fresh perspectives on the democratization of healthcare.
Key topics to be addressed in this panel include: How can direct-to-consumer recruitment models accelerate the pace of clinical trials? How can technology based approaches to trial site management optimize end-to-end trial execution? The panelists with also take a deep dive into the numbers, using real-world case studies to quantify the value of early adoption of innovative approaches to clinical studies and the advantages of cohesive, operationally seamless models.
Ability Level: All
Session ID: 503675